Advertisement
Screener

ORAGENICS, INC. (OGEN) Proceeds from (Repayments of) Short-term Debt

0.9 / 5 stars · 10/53 Roast Me

ORAGENICS, INC. Proceeds from (Repayments of) Short-term Debt

ORAGENICS, INC. (OGEN) reported Proceeds from (Repayments of) Short-term Debt of -$129.38 thousand for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-14.

Discontinued › Cash Flow › Financing Activities

us-gaap:ProceedsFromRepaymentsOfShortTermDebt · last filed 2019-08-14

  • ORAGENICS, INC. proceeds from (repayments of) short-term debt for the quarter ending 2019-06-30 was -$65.00K.
  • ORAGENICS, INC. proceeds from (repayments of) short-term debt for the quarter ending 2019-03-31 was -$64.38K.
  • ORAGENICS, INC. proceeds from (repayments of) short-term debt for the quarter ending 2018-12-31 was -$66.19K.
  • ORAGENICS, INC. proceeds from (repayments of) short-term debt for the quarter ending 2018-09-30 was -$46.08K.
  • ORAGENICS, INC. proceeds from (repayments of) short-term debt for fiscal 2018 was -$200.75K.
  • ORAGENICS, INC. proceeds from (repayments of) short-term debt for fiscal 2017 was -$157.95K.
  • ORAGENICS, INC. proceeds from (repayments of) short-term debt for fiscal 2016 was -$158.10K.
  • ORAGENICS, INC. proceeds from (repayments of) short-term debt for fiscal 2015 was -$159.95K.
Period endProceeds from (Repayments of) Short-term Debt 3 monthProceeds from (Repayments of) Short-term Debt 6 monthProceeds from (Repayments of) Short-term Debt 9 monthProceeds from (Repayments of) Short-term Debt 12 month
2019-06-30-$65.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14
-$129.38K
10-Q · filed 2019-08-14
-$195.57K
derived: sum of 3 quarters · filed 2019-08-14
-$241.65K
derived: sum of 4 quarters · filed 2019-08-14
2019-03-31-$64.38K
10-Q · filed 2019-05-13
-$130.57K
derived: sum of 2 quarters · filed 2019-05-13
-$176.65K
derived: sum of 3 quarters · filed 2019-05-13
-$223.50K
derived: sum of 4 quarters · filed 2019-08-14
2018-12-31-$66.19K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29
-$112.27K
derived: sum of 2 quarters · filed 2019-03-29
-$159.13K
derived: sum of 3 quarters · filed 2019-08-14
-$200.75K
10-K · filed 2019-03-29
2018-09-30-$46.08K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13
-$92.93K
derived: sum of 2 quarters · filed 2019-08-14
-$134.56K
10-Q · filed 2018-11-13
-$182.15K
derived: sum of 4 quarters · filed 2019-08-14
2018-06-30-$46.85K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14
-$88.48K
10-Q · filed 2019-08-14
-$136.07K
derived: sum of 3 quarters · filed 2019-08-14
-$170.63K
derived: sum of 4 quarters · filed 2019-08-14
2018-03-31-$41.63K
10-Q · filed 2019-05-13
-$89.22K
derived: sum of 2 quarters · filed 2019-05-13
-$123.78K
derived: sum of 3 quarters · filed 2019-05-13
-$164.06K
derived: sum of 4 quarters · filed 2019-05-13
2017-12-31-$47.59K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29
-$82.14K
derived: sum of 2 quarters · filed 2019-03-29
-$122.43K
derived: sum of 3 quarters · filed 2019-03-29
-$157.95K
10-K · filed 2019-03-29
2017-09-30-$34.55K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13
-$74.84K
derived: sum of 2 quarters · filed 2018-11-13
-$110.35K
10-Q · filed 2018-11-13
-$155.68K
derived: sum of 4 quarters · filed 2018-11-13
2017-06-30-$40.29K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13
-$75.80K
10-Q · filed 2018-08-13
-$121.13K
derived: sum of 3 quarters · filed 2018-08-13
-$155.93K
derived: sum of 4 quarters · filed 2018-08-13
2017-03-31-$35.51K
10-Q · filed 2018-05-15
-$80.84K
derived: sum of 2 quarters · filed 2018-05-15
-$115.64K
derived: sum of 3 quarters · filed 2018-05-15
-$159.67K
derived: sum of 4 quarters · filed 2018-05-15
2016-12-31-$45.33K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16
-$80.13K
derived: sum of 2 quarters · filed 2018-02-16
-$124.15K
derived: sum of 3 quarters · filed 2018-02-16
-$158.10K
10-K · filed 2018-02-16
2016-09-30-$34.80K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31
-$78.82K
derived: sum of 2 quarters · filed 2017-10-31
-$112.77K
10-Q · filed 2017-10-31
-$158.93K
derived: sum of 4 quarters · filed 2017-10-31
2016-06-30-$44.02K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14
-$77.97K
10-Q · filed 2017-08-14
-$124.13K
derived: sum of 3 quarters · filed 2017-08-14
-$158.45K
derived: sum of 4 quarters · filed 2017-08-14
2016-03-31-$33.95K
10-Q · filed 2017-05-15
-$80.11K
derived: sum of 2 quarters · filed 2017-05-15
-$114.43K
derived: sum of 3 quarters · filed 2017-05-15
-$159.05K
derived: sum of 4 quarters · filed 2017-05-15
2015-12-31-$46.16K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27
-$80.48K
derived: sum of 2 quarters · filed 2017-02-27
-$125.11K
derived: sum of 3 quarters · filed 2017-02-27
-$159.95K
10-K · filed 2017-02-27
2015-09-30-$34.32K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14
-$78.95K
derived: sum of 2 quarters · filed 2016-11-14
-$113.79K
10-Q · filed 2016-11-14
-$158.52K
derived: sum of 4 quarters · filed 2016-11-14
2015-06-30-$44.62K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15
-$79.47K
10-Q · filed 2016-08-15
-$124.19K
derived: sum of 3 quarters · filed 2016-08-15
-$158.71K
derived: sum of 4 quarters · filed 2016-08-15
2015-03-31-$34.84K
10-Q · filed 2016-05-16
-$79.57K
derived: sum of 2 quarters · filed 2016-05-16
-$114.08K
derived: sum of 3 quarters · filed 2016-05-16
-$158.64K
derived: sum of 4 quarters · filed 2016-05-16
2014-12-31-$44.72K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30
-$79.24K
derived: sum of 2 quarters · filed 2016-03-30
-$123.79K
derived: sum of 3 quarters · filed 2016-03-30
-$158.21K
10-K · filed 2016-03-30
2014-09-30-$34.52K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06
-$79.07K
derived: sum of 2 quarters · filed 2015-11-06
-$113.49K
10-Q · filed 2015-11-06
2014-06-30-$44.55K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07
-$78.97K
10-Q · filed 2015-08-07
2014-03-31-$34.42K
10-Q · filed 2015-05-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
JUPITER NEUROSCIENCES, INC. (JUNS)United States$0.002B-0.02
BioXcel Therapeutics, Inc. (BTAI)United States$0.002B
Nexentis Technologies Inc. (NXTS)$0.002B
Decoy Therapeutics Inc. (DCOY)United States$0.002B-0.27
ZyVersa Therapeutics, Inc. (ZVSA)United States$0.002B
Matinas BioPharma Holdings, Inc. (MTNB)United States$0.003B
Petros Pharmaceuticals, Inc. (PTPI)United States$0.003B
GeoVax Labs, Inc. (GOVX)United States$0.003B-0.45
Silo Pharma, Inc. (SILO)United States$0.003B-1.57
Genprex, Inc. (GNPX)United States$0.003B-0.02